Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Regogfinib in the Treatment of Advanced Hepatocellular Carcinoma

NCT05557656 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT05557656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Regogfinib in the Treatment of Advanced Hepatocellular Carcinoma
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 5, 2023
Completion date
December 31, 2023
Enrollment
800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma